Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Nilotinib
Original notice title
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Nilotinib (ATC-Code nach WHO: L01EA03)
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
40 / 100
Risk factors
No minimum volume; actual demand depends on prescription behavior and patient numbers.
Buyer may terminate if exclusive agreements (typically after 8-12 months) are concluded.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jul 2026
- Supply of Nilotinib (ATC L01EA03) under a non-exclusive framework agreement.
- Excludes Nilotinib dispersed in apple sauce unless patented.
Show full summary
Non-exclusive drug discount agreement for Nilotinib (ATC L01EA03) via an Open-House model. Contract ends 31.07.2026. Open to all qualified pharmaceutical entrepreneurs meeting German statutory requirements. No guaranteed volumes or exclusivity. Estimated value not published. Submission possible periodically until final deadline.
Risks
No minimum volume; actual demand depends on prescription behavior and patient numbers.
Buyer may terminate if exclusive agreements (typically after 8-12 months) are concluded.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as per §4 Abs. 18 AMG for the offered medicinal products.
- Legal seat within Germany, EU, or EEA (§9 Abs. 2 AMG).
Eligibility
- No exclusion grounds under §§123, 124 GWB (submission of self-declaration).
Requirements may be incomplete.
Buyer
Name
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen hier einschließlich für die AOK PLUS service GmbH und die Laurat Grundstücksverwaltungs-Gesellschaft mbH
Location
Dresden, DEU
Website
Buyer profile
Identifier
DE256878834
Activity
Health
Lots (1)
LOT-0001
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Nilotinib
Single lot covering Nilotinib (excluding apple sauce dispersion unless patented). Open House model – any qualified pharmaceutical entrepreneur may join by submitting required documents. No negotiation or exclusivity.
Location
Duration
Category
Deadline
Award details
Selection criteria
Value note
Show original TED data
Original lot title
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Nilotinib (ATC-Code nach WHO: L01EA03)
Original TED description
Siehe Kurzbeschreibung
Procurement Details
- Publication date
- 29 maj 2025
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 349678-2025
Documents (1)
Similar tenders
Spain – Microelectronic machinery and apparatus – Suministro e instalación de un equipo de litografía óptica de proyección en el ultravioleta profundo, destinado al Instituto de Microelectrónica de Barcelona de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Poland – Laboratory, optical and precision equipments (excl. glasses) – 76.2026 Dostawa sprzętu laboratoryjnego na potrzeby jednostek organizacyjnych Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu
France – Market and economic research; polling and statistics – Appel d'offres relatif à des prestations de service sur l'écoute des usagers et collectivités desservies par le service public de l'eau
France – Telephone network maintenance services – Maintenance préventive et corrective des autocommutateurs téléphoniques privés
Hungary – Electrical supplies and accessories – Szabadvezetéki szerelvények II. 2026 - Démász
Estonia – Consultative engineering and construction services – Põhjamaade-Balti vesinikukoridori ja selle toimimiseks vajaliku taristu riigi eriplaneeringu koostamine Majandus- ja Kommunikatsiooniministeeriumile
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
40 / 100
Risk factors
No minimum volume; actual demand depends on prescription behavior and patient numbers.
Buyer may terminate if exclusive agreements (typically after 8-12 months) are concluded.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications